Skip to main content
TradingView validation

Validate before TradingView deployment.

TradingView is excellent for charting and running Pine scripts. Strategy Arena sits before that moment: test the strategy, expose weak assumptions, then export only when the system deserves it.

World Arena9native markets tracked
Strategy x arena rows150+current public snapshot
Unique signalMDRMarket Difficulty Rating

Why this page exists

Google already tests Strategy Arena on AI trading arena, AI trading leaderboard, AI trading competition and Alpha Arena queries. This page gives a direct, verifiable answer connected to public datasets instead of sending users to a generic blog post.

Before TradingView

A chart backtest can look convincing while still ignoring robustness, friction and market regime changes. Strategy Arena adds a validation layer before a script is treated as production-ready.

Import, test, export

Builders can bring Pine logic into Strategy Arena, compare it with arena baselines, run robustness checks, then use the Pine v5 export path for validated ArenaScript strategies.

Production layer

Most of Strategy Arena remains free to explore. The Lab assembler is Lab 0. Builder keeps private report history after a useful result; Operator covers MCP/API keys, heavier GPU backtests and deeper matrices.

TradingView Workflow

StepWhat Strategy Arena checksOutput
1. Pine importTradingView logic is converted into a simulatable strategy, with parser limits stated explicitly./pine-converter
2. BacktestThe strategy runs on arena data with fees, spread and slippage instead of a too-clean backtest./backtest
3. RobustesseMonte Carlo, regimes, drawdown and Buy & Hold comparison separate edge from noise.Monte Carlo facts
4. HospitalFragile strategies do not disappear: they move to WATCH, RECALIBRATE, BUG_SUSPECT or DEPRECATED.Strategy Hospital
5. ExportWhen the strategy deserves production use, Builder exports Pine v5 and Operator opens MCP/API access for agents.Builder / Operator layer
Production layer Validated enough? Export or automate it.

Keep exploring and opening public TradingView links for free. Builder is for private exports; Operator is for MCP/API, CUDA evolution and advanced verification.

TradingView partner path

Start with a chart and a price alert.

The free Starter needs no Lab installation or Strategy Arena account. First TradingView account: disclosed partner path. Existing account: neutral link. Evaluating a strategy is a separate task.

01 · ChooseAn instrument and its source
02 · SaveYour first daily chart
03 · ObserveA price alert, not an order

Partner coupon context · Affiliate disclosure: Strategy Arena may receive a commission if a first-time user later buys an eligible web subscription. Partner attribution is for first-time users and web purchases only. Account setup does not validate a strategy; exact strategy code remains proof-gated. No purchase is required for the Starter. Any coupon is subject to TradingView's purchase conditions, not granted for an account opening or a KEEP verdict.

Public badge Validated on Strategy Arena Backtest · Monte Carlo · Hospital checked

For published Pine scripts

A creator can show that an idea passed through the lab, without promising returns. The badge points to the validation method, not financial advice.

<a href="https://strategyarena.io/tradingview-strategy-validation">Validated on Strategy Arena</a>

FAQ

Can Strategy Arena validate a TradingView strategy?

Yes. Pine logic can be imported for simulation and analysis, then compared against Strategy Arena validation surfaces such as fees, slippage, Monte Carlo and Strategy Hospital.

Can Strategy Arena export to TradingView?

Yes. The MCP workflow exposes export_to_tradingview, which compiles ArenaScript strategies to Pine Script v5 with arena fee and slippage assumptions.

Is this an official TradingView partnership?

No. Strategy Arena is an independent validation and research platform. TradingView is referenced as a deployment and charting destination for Pine Script workflows.

Continue

Public paper-trading and research. Not financial advice, no return promise.